Article Sidebar

Download
Download Article

Main Article Content

Abstract

Force majeure clauses in contracts are usually used as a complement to business agreements. The absence of special regulations that regulate in detail the force majeure clause often causes problems in the preparation of contracts. The force majeure clause became important and was widely used during the Covid-19 pandemic as a legal basis to overcome obstacles in the implementation of the parties' obligations due to unforeseen circumstances., through the Contract for the Purchase of Sars-Cov-2 Vaccine (Vero Cells), Inactivity or Covid-19 Vaccine (Vero Cells), Until now, the force majeure benchmark in the applicable legal provisions in Indonesia is regulated in a limited manner in Articles 1244-1245 of the Civil Code. The research method used was juridical normative by analyzing the force majeure clause in the Sars-CoV-2 Vaccine Purchase Contract (Vero Cell), Inactive or Covid-19 Vaccine (Vero Cell), Inactive between PT. Kimia Farma Tbk and Sinopharm China. The results of the study show that Article 10 Paragraph (4) of the Sars-CoV-2 Vaccine Purchase Contract (Vero Cell), Inactivation or Covid-19 Vaccine (Vero Cell), Deactivated between PT. Kimia Farma Tbk and Sinopharm China did not comply with one of the provisions in Articles 1244-1245 of the Civil Code, namely: elements that were not anticipated beforehand. Based on the results of the analysis, this study is expected to provide legal recommendations for the preparation of force majeure clauses in international business contracts in the future to be more in line with the principles of Indonesian civil law.

Keywords

Force Majeure Business Contracts Covid-19 Pandemic

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite
Herlan, A., Masturi, F. N., & Iryatin, A. F. N. (2025). Force Majeure Clause in the Covid-19 Vaccine Purchase Contract between Kimia Farma Tbk and Sinopharm. Golden Ratio of Law and Social Policy Review, 5(1), 210–217. https://doi.org/10.52970/grlspr.v5i1.1694
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Arini, A. D. (2019). Corona pandemic as a force majeure reason in business contracts. Institutional Repository, 9(1).
  2. Bio Farma (Persero). (2021). Letter No. SD-057.01/DIR/III/2021 concerning support for import and distribution cooperation in the import and distribution of Sinopharm COVID-19 vaccine.
  3. Cahaya Suhandi. (2012). The judge's view on force majeure. Journal of Law & Development, 42(4), 519. https://doi.org/10.21143/jhp.vol42.no4.265
  4. Civil Code. (2007). KUHP: Kode Perdata.
  5. David. (2018). Legal protection for trademark holders in the distributor agreement between Eagle Indo Pharma Tangerang as principal and Distrindo Bintang Agung Medan as a distributor of Eucalyptus Cap Lang Oil [Undergraduate thesis, Medan Area University].
  6. Dewangker, A. E. P. (2020). The use of force majeure clauses in pandemic conditions. Journal of Education and Development, 8(3), 309–313. http://journal.ipts.ac.id/index.php/ED/article/view/1959
  7. Habeahan, B., & Siallagan, S. R. (2021). A legal review of force majeure in the implementation of business contracts during the COVID-19 pandemic. Journal of Legal Opinion Nommensen, 2(2), 168–180. https://doi.org/10.51622/njlo.v2i02.369
  8. Hidayat, M. R., & Komarudin, P. (2017). Review of loan contract law regarding force majeure provisions in civil law, 17(1).
  9. I Gst. Agung Rio Diputra. (2018). Implementation of contract design in creating business contract structures. Acta Comitas, 3(3), 549–560.
  10. KlikLegal. (2020). Is COVID-19 automatically the basis for the implementation of force majeure? KlikLegal.com. https://kliklegal.com/apakah-covid-19-automatic-becomes-the-basis-of-application-force-majeure/
  11. Kusumohamidjojo, B. (2004). Guidelines for contract preparation. PT Grasindo.
  12. Mckendrick, E. (1995). Force majeure and contract frustration (2nd ed.). Routledge.
  13. Melis, W. (1984). Force majeure and hardship clauses in international commercial contracts, given the practice of ICC arbitral tribunals. International Journal of Arbitration, 1(3), 213–221. https://doi.org/10.54648/joia1984023
  14. Minister of Health of the Republic of Indonesia. (2020). Decree of the Minister of Health of the Republic of Indonesia Number HK.01.07/MENKES/12758/2020 concerning the determination of vaccine types for Coronavirus Disease (COVID-19) vaccination services.
  15. Minister of SOEs of the Republic of Indonesia. (2021). Letter No. S-164/MBU/03/2021 concerning support for the import and distribution of COVID-19 vaccine products with Sinopharm.
  16. President of the Republic of Indonesia. (2020). Regulation of the President of the Republic of Indonesia Number 99 of 2020 concerning vaccine procurement and implementation of vaccination in the context of handling the COVID-19 pandemic.
  17. President of the Republic of Indonesia. (2021). Regulation of the President of the Republic of Indonesia Number 14 of 2021 concerning amendments to Regulation Number 99 of 2020 concerning vaccine procurement and implementation of vaccination in the context of handling the COVID-19 pandemic.
  18. Rohaya, N., Faculty of Law, University of Muhammadiyah. (2018). Prohibition of the use of standard clauses. Exemption Clause, 6(1).
  19. Rousseau, A. B., & Augenblick, M. (2012). Force majeure in tumultuous times: Impracticability as the new impossibility. The Journal of World Investment & Trade, 13(1), 59–75. https://doi.org/10.1163/221190012x621535
  20. Soemadipradja, R. S. S. (2010). Explanation of force majeure law: Provisions for cancellation of agreements caused by force majeure. PT Gramedia.
  21. Sumitro, R. H. (2005). Normative law research. Kencana.
  22. Tbk, Kimia Farma, China National Biotec Group Company Limited, & Beijing Institute of Biological Product Co., Ltd. (2019). Sars-CoV-2 vaccine purchase contract (Vero Cell), inactivated vaccine or Covid-19 (Vero Cell), deactivated between Kimia Farma Tbk and Sinopharm.
  23. Toso de Alcântara, B. (2020). The coronavirus pandemic and its impact on cybersecurity (pp. 1–18).
  24. Widjaja, G., & Muljadi, K. (2003). Buying and selling. PT RajaGrafindo Persada.